These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 26712006)

  • 1. Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex.
    Hua G; Ganti KP; Chambon P
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E635-43. PubMed ID: 26712006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.
    Hua G; Paulen L; Chambon P
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E626-34. PubMed ID: 26712002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
    Ki SH; Cho IJ; Choi DW; Kim SG
    Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trilogy of glucocorticoid receptor actions.
    Tan CK; Wahli W
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1115-7. PubMed ID: 26792523
    [No Abstract]   [Full Text] [Related]  

  • 7. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.
    Yang F; Ma Q; Liu Z; Li W; Tan Y; Jin C; Ma W; Hu Y; Shen J; Ohgi KA; Telese F; Liu W; Rosenfeld MG
    Mol Cell; 2017 May; 66(3):321-331.e6. PubMed ID: 28475868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
    Hong W; Baniahmad A; Li J; Chang C; Gao W; Liu Y
    FEBS Lett; 2009 Aug; 583(15):2451-6. PubMed ID: 19595997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression.
    Ito K; Yamamura S; Essilfie-Quaye S; Cosio B; Ito M; Barnes PJ; Adcock IM
    J Exp Med; 2006 Jan; 203(1):7-13. PubMed ID: 16380507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements.
    Ramamoorthy S; Cidlowski JA
    Mol Cell Biol; 2013 May; 33(9):1711-22. PubMed ID: 23428870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
    Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
    J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balanced control of thermogenesis by nuclear receptor corepressors in brown adipose tissue.
    Richter HJ; Hauck AK; Batmanov K; Inoue SI; So BN; Kim M; Emmett MJ; Cohen RN; Lazar MA
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2205276119. PubMed ID: 35939699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transrepression function of the glucocorticoid receptor regulates eyelid development and keratinocyte proliferation but is not sufficient to prevent skin chronic inflammation.
    Donet E; Bosch P; Sanchis A; Bayo P; Ramírez A; Cascallana JL; Bravo A; Pérez P
    Mol Endocrinol; 2008 Apr; 22(4):799-812. PubMed ID: 18174358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor.
    Surjit M; Ganti KP; Mukherji A; Ye T; Hua G; Metzger D; Li M; Chambon P
    Cell; 2011 Apr; 145(2):224-41. PubMed ID: 21496643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
    Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
    Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression and modification of silencing mediator of retinoic acid and thyroid hormone receptors involved in the pathogenesis of tumoral cortisol resistance.
    Jiang J; Li N; Wang X; Lu Y; Bi Y; Wang W; Li X; Ning G
    Endocrinology; 2010 Aug; 151(8):3697-705. PubMed ID: 20555024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.